US FDA Implementing Hybrid Work Policy In January

Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.

FDA hybrid work
Individual duties will help determine whether on-site, telework and remote working options will be available for FDA employees. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

The US Food and Drug Administration will not require all employees to resume their daily treks to the office going forward, choosing a “hybrid workplace model” that will go into effect in January 2023.

Commissioner Robert Califf made the change after the agency completed a six-month pilot exploring workplace flexibilities

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation